Show simple item record

dc.contributor.authorArthurs, Owen J.en_US
dc.contributor.authorvan Rijn, Rick R.en_US
dc.contributor.authorGranata, Claudioen_US
dc.contributor.authorPorto, Lucianaen_US
dc.contributor.authorHirsch, F Wolfgangen_US
dc.contributor.authorRosendahl, Karenen_US
dc.date.accessioned2020-03-18T11:25:45Z
dc.date.available2020-03-18T11:25:45Z
dc.date.issued2019
dc.PublishedArthurs OJ, van Rijn RR, Granata C, Porto, Hirsch, Rosendahl K. European Society of Paediatric Radiology 2019 strategic research agenda: improving imaging for tomorrow’s children. Pediatric Radiology. 2019;49(8):983-989eng
dc.identifier.issn0301-0449
dc.identifier.issn1432-1998
dc.identifier.urihttps://hdl.handle.net/1956/21522
dc.description.abstractThe European Society of Paediatric Radiology (ESPR) research committee was established to initiate, drive forward and foster excellence in paediatric imaging, paediatric image-guided intervention and radiation protection research, by facilitating more evidence-based standards, protocols and multi-institutional collaborations. The ESPR Strategic Research Agenda outlines our current research approach, highlighting several areas of paediatric imaging where the society can help guide current and future research, and emphasizing those areas where early research (“seed”) funding may need to be allocated by this and other societies as precursors to larger grant applications. The key aims are to evaluate normal variation in order to be able to confidently diagnose disease states, develop robust image-based classification systems to aid diagnosis and treatment monitoring, and help develop evidence-based clinical guidelines using current literature and experience to identify knowledge gaps. For this reason, the development of evidence-based imaging pipelines, broken down step-by-step to include diagnosis, classification and clinical effectiveness, should be the end goal for each disease entity for each affected child. Here, we outline the 2019 ESPR Strategic Research Agenda along three points in the clinical imaging pipeline: clinical referral, disease diagnosis and evolution, and clinical therapeutic evaluation and effectiveness. Through multicentre trials, using existing high-level experience and expertise, and nurturing the next generation of researchers, we will be able to achieve these aims.en_US
dc.language.isoengeng
dc.publisherSpringereng
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/4.0eng
dc.titleEuropean Society of Paediatric Radiology 2019 strategic research agenda: improving imaging for tomorrow’s childrenen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2019-12-13T12:11:43Z
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2019 The Author(s)
dc.identifier.doihttps://doi.org/10.1007/s00247-019-04406-4
dc.identifier.cristin1714314
dc.source.journalPediatric Radiology


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY